Use of the teleclinic significantly reduced the rate of heart transplant surgery (P = 0.007), readmission (P = 0.006), and improved heart failure (P = 0.002) compared to before the Covid-19 pandemic.Long-term teleclinic use significantly reduced the dosage of angiotensin-converting enzyme inhibitors (P = 0.006), beta-blockers (P = 0.001), furosemide (P = 0.002), and tolvaptan (P = 0.002). Here, ACE is linked to heart failure.